Segmented oral miniparticles combine fast and modified release to improve bioavailability while reducing local gastrointestinal irritation.
An aqueous binder granulation route turns azo powders into spherical, crush-resistant granules that cut dust, caking, and handling risks.
Oil-coated microspheres and a quickly separating oil-water emulsion help eye drops stay lubricating longer and spread under the eyelids.
Water-soluble drying agents control moisture without prolonged drying, improving flowability and protecting moisture-sensitive active ingredients.
A fluidized-bed xanthan gum coating protects cranberry granules from PACs oxidation, preserving bioactivity and storage stability.
A uniform Wurster-applied coating isolates BHB free acid crystals from moisture, preventing deliquescence and self-polymerization.
Temperature-responsive PVA and methylcellulose coatings delay electrolyte release until body heat rises, extending hydration support during exertion.
High-shear granulation of plant carrier powder and organic syrup delivers natural tablet excipients with strong flow, compressibility, and uniform filling.
Homogeneous emulsification and spray drying produce injectable PLA microspheres that resist agglomeration and maintain consistent degradation.
A spouted-bed granulation process turns poorly flowing API powders into stable, flowable granules for high drug-load dosage forms.
Using mist droplets no larger than the core particles, this granulation approach shortens drug coating time and reduces oxidation exposure.